ARWR Logo

Arrowhead Pharmaceuticals, Inc. (ARWR) 

NASDAQ$15.095
Market Cap
$2.07B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
311 of 924
Rank in Industry
178 of 527

ARWR Insider Trading Activity

ARWR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$82,990313
Sells
$10,368,3512187

Related Transactions

Lu Hongbodirector3$82,9900$0$82,990
OLUKOTUN ADEOYE Ydirector0$02$77,139$-77,139
GIVEN DOUGLAS Bdirector0$02$121,556$-121,556
Waddill William D.director0$02$164,665$-164,665
Oliver TracieChief Commercial Officer0$01$237,480$-237,480
Vakiener Victoriadirector0$02$238,993$-238,993
O'Brien PatrickCOO and General Counsel0$02$736,059$-736,059
Hamilton James CChief Discovery/Trans Medicine0$02$817,004$-817,004
Myszkowski Kenneth AllenChief Financial Officer0$02$893,095$-893,095
Anzalone Christopher RichardChief Executive Officer0$06$7.08M$-7.08M

About Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in Phase 2b clinical trial to reduce production of angiopoietin-like protein 3; ARO-HSD, which is in â€¦

Insider Activity of Arrowhead Pharmaceuticals, Inc.

Over the last 12 months, insiders at Arrowhead Pharmaceuticals, Inc. have bought $82,990 and sold $10.37M worth of Arrowhead Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Arrowhead Pharmaceuticals, Inc. have bought $52,573 and sold $21.24M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Lu Hongbo (director) — $82,990.

The last purchase of 1,000 shares for transaction amount of $27,500 was made by Lu Hongbo (director) on 2024‑03‑20.

List of Insider Buy and Sell Transactions, Arrowhead Pharmaceuticals, Inc.

2025-03-13SaleAnzalone Christopher RichardChief Executive Officer
51,425
0.0374%
$15.07$774,975+1.92%
2025-03-04SaleAnzalone Christopher RichardChief Executive Officer
133,333
0.104%
$17.02$2.27M-9.53%
2025-03-03SaleAnzalone Christopher RichardChief Executive Officer
166,667
0.1344%
$18.03$3.01M-11.91%
2025-01-23SaleOLUKOTUN ADEOYE Ydirector
959
0.0007%
$21.00$20,139-11.24%
2025-01-07SaleO'Brien PatrickCOO and General Counsel
8,000
0.0065%
$19.69$157,520-2.85%
2025-01-07SaleMyszkowski Kenneth AllenChief Financial Officer
18,000
0.0146%
$19.69$354,500-2.85%
2025-01-06SaleO'Brien PatrickCOO and General Counsel
29,184
0.0236%
$19.82$578,539-0.92%
2025-01-06SaleMyszkowski Kenneth AllenChief Financial Officer
27,167
0.022%
$19.83$538,595-0.92%
2025-01-06SaleHamilton James CChief Discovery/Trans Medicine
32,729
0.0265%
$19.82$648,824-0.92%
2025-01-02SaleAnzalone Christopher RichardChief Executive Officer
11,520
0.009%
$19.05$219,456-0.69%
2024-12-27SaleOLUKOTUN ADEOYE Ydirector
2,850
0.0024%
$20.00$57,000+2.85%
2024-12-23SaleAnzalone Christopher RichardChief Executive Officer
12,563
0.0099%
$19.59$246,109-1.19%
2024-12-18SaleAnzalone Christopher RichardChief Executive Officer
26,712
0.0226%
$21.24$567,486-4.22%
2024-12-17SaleGIVEN DOUGLAS Bdirector
547
0.0004%
$22.04$12,056-12.37%
2024-12-17SaleWaddill William D.director
3,747
0.003%
$22.04$82,584-12.37%
2024-12-16SaleGIVEN DOUGLAS Bdirector
5,000
0.004%
$21.90$109,500-12.70%
2024-12-16SaleWaddill William D.director
3,748
0.003%
$21.90$82,081-12.70%
2024-12-16SaleVakiener Victoriadirector
8,994
0.0071%
$21.91$197,059-12.70%
2024-07-02SaleOliver TracieChief Commercial Officer
9,394
0.0073%
$25.28$237,480-19.19%
2024-05-02SaleVakiener Victoriadirector
1,799
0.0014%
$23.31$41,935-11.15%
Total: 232
*Gray background shows transactions not older than one year

Insider Historical Profitability

24.46%
Anzalone Christopher RichardChief Executive Officer
4062377
2.9584%
$61.32M441<0.0001%
Myszkowski Kenneth AllenChief Financial Officer
455433
0.3317%
$6.87M129<0.0001%
GIVEN DOUGLAS Bdirector
124167
0.0904%
$1.87M121<0.0001%
Lu Hongbodirector
33680
0.0245%
$508,399.6030
KNOTT DAVID M10 percent owner
166778
0.1215%
$2.52M13<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$66,492,695
135
27.65%
$2.05B
$1,376,668
53
18.46%
$2.31B
$11,583,737
45
49.75%
$1.76B
$224,267,561
40
26.78%
$2.17B
$148,770,544
34
80.63%
$1.74B

ARWR Institutional Investors: Active Positions

Increased Positions137+43.63%10M+10.01%
Decreased Positions131-41.72%8M-7.87%
New Positions45New2MNew
Sold Out Positions44Sold Out2MSold Out
Total Postitions320+1.91%101M+2.14%

ARWR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$248,494.0011.81%16.18M+342,088+2.16%2024-12-31
Vanguard Group Inc$187,151.008.89%12.18M-44,766-0.37%2024-12-31
Avoro Capital Advisors Llc$170,667.008.11%11.11M+2M+25%2024-12-31
State Street Corp$92,409.004.39%6.02M-338,104-5.32%2024-12-31
Slate Path Capital Lp$80,364.003.82%5.23M+347,000+7.1%2024-12-31
Fmr Llc$78,353.003.72%5.1M-966,486-15.93%2024-12-31
Geode Capital Management, Llc$45,388.002.16%2.95M-9,172-0.31%2024-12-31
Siren, L.L.C.$44,570.002.12%2.9M+442,903+18.01%2024-12-31
T. Rowe Price Investment Management, Inc.$38,512.001.83%2.51M-1M-29.86%2024-12-31
Norges Bank$31,555.001.5%2.05M+469,044+29.59%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
2.13SellsBuysStrong BuyBuyHoldSellStrong SellARWRHighAverageLowSeries 4